Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Neovate Capital Partners is a venture capital firm based in the United States, focusing on early-stage life sciences investments. The firm specializes in transformational medical devices and category-defining therapeutics, particularly at critical pre-inflection points. They target investments in the biotech and healthcare sectors.
Neovate Capital Partners invests in interventional solutions that drive new paradigms in care, including neuromodulation and tissue regeneration. Their focus extends to robotic and AI-enabled systems that enhance precision and efficiency in medical procedures. The firm typically engages at the pre-seed, seed, and seed+ stages, aiming to identify breakthrough technologies before they gain widespread consensus.
Notable portfolio company Biorez developed a tendon/ligament healing implant and was acquired by ConMed in 2022 for $250 million.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.